Markus Schmidt will give a keynote presentation at the 2014 Pixelache Festival in Helsinki, Finnland, 6th June 2014.

In the case of Bio-commons, developments in biotechnology rely mainly on patents as means to enable and secure innovations. The new field of synthetic biology, however, entails not only classical intellectual property protection but also attempts to establish open access and open source to key biotech methods and processes. How will the two cultures evolve? Will one approach dominate or will they coexist?